1 |
Udommethaporn S, Tencomnao T, McGowan EM, Boonyaratanakornkit V. 2016. Assessment of anti-TNF- activities in keratinocytes expressing inducible TNF- : A novel tool for anti-TNF- drug screening. PLoS One 11: e0159151.
DOI
|
2 |
Lapara NJ 3rd, Kelly BL. 2010. Suppression of LPS-induced inflammatory responses in acrophages infected with Leishmania. J. Inflamm (Lond). 7: 8.
DOI
|
3 |
Zhang X, Li N, Shao H, Meng Y, Wang L, Wu Q, et al. 2016. Methane limit LPS-induced NF-/MAPKs signal in macrophages and suppress immune response in mice by enhancing PI3K/AKT/GSK--mediated IL-10 expression. Sci. Rep. 11: 6.
|
4 |
Gao HM, Liu B, Zhang W, Hong JS. 2003. Novel anti-inflammatory therapy for Parkinson's disease. Trends Pharmacol. Sci. 24: 395-401.
DOI
|
5 |
Copeland S, Warren HS, Lowry SF, Calvano SE, Remick D. 2005. Acute inflammatory response to endotoxin in mice and humans. Clin. Diagn. Lab. Immunol. 12: 60-67.
DOI
|
6 |
Roos-Engstrand E, Wallin A, Bucht A, Pourazar J, Sandstrom T, Blomberg A. 2005. Increased expression of p38 MAPK in human bronchial epithelium after lipopolysaccharide exposure. Eur. Respir. J. 25: 797-803.
DOI
|
7 |
Soromou LW, Zhang Z, Li R, Chen N, Guo W, Huo M, et al. 2012. Regulation of inflammatory cytokines in lipopolysaccharidestimulated RAW 264.7 murine macrophage by 7-O-methylnaringenin. Molecules 17: 3574-3585.
DOI
|
8 |
Lee HJ, Oh TH, Yoon WJ, Kang GJ, Yang EJ, Park SS, et al. 2008. Eutigoside C inhibits the production of inflammatory mediators (NO, PGE2, IL-6) by down-regulating NF- and MAP kinase activity in LPS-stimulated RAW 264.7 cells. J. Pharm. Pharmacol. 60: 917-924.
DOI
|
9 |
Yang G, Lee K, Lee M, Ham I, Choi HY. 2012. Inhibition of lipopolysaccharide-induced nitric oxide and prostaglandin production by chlo-roform fraction of Cudrania tricuspidata in RAW 264.7 macrophages. BMC Complement. Altern. Med. 12: 250.
|
10 |
Gomez I, Foudi N, Longrois D, Norel X. 2013. The role of prostaglandin in human vascular inflammation. Prostaglandins Leukot. Essent. Fatty Acids 89: 55-63.
DOI
|
11 |
Yeom M, Kim JH, Min JH, Hwang MK, Jung HS, Sohn Y. 2015. Xanthii fructus inhibits inflammatory responses in LPS-stimulated RAW 264.7 macrophages through suppressing NF- and JNK/p38 MAPK. J. Ethnpharmacol. 24: 394-401.
|
12 |
Kim JB, Han AR, Park EY, Kim JY, Cho W, Lee J, et al. 2007. Inhibition of LPS-induced iNOS, COX-2 and cytokines expression by poncirin through the NF- inactivation in RAW 264.7 macrophage cells. Biol. Pharm. Bull. 30: 2345-2351.
DOI
|
13 |
Lawrence T. 2009. The nuclear factor NF- pathway in inflammation. Cold Spring Harbor Perspect. Biol. 1: a001651.
DOI
|
14 |
Tak PP, Firestein GS. 2001. NF-: a key role in inflammatory diseases. J. Clin. Invest. 107: 7-11.
DOI
|
15 |
Fang H, Pengal RA, Cao X, Ganesan LP, Wewers MD, Marsh CB, et al. 2004. Lipopolysaccharide-induced macrophage inflammatory response is regulated by SHIP. J. Immunol. 173: 360-366.
DOI
|
16 |
Frazier WJ, Xue J, Luce WA, Liu Y. 2012. MAPK signaling drives inflammation in LPS-stimulated cardiomyocytes: the route of crosstalk to G-protein-coupled receptors. PLoS One. 7:e50071.
DOI
|
17 |
Imai Y, Sato S, Tanaka Y, Ochi K, Hosaka T. 2015. Lincomycin at subinhibitory concentrations potentiates secondary metabolite production by Streptomyces spp. Appl. Environ. Microbiol. 81: 3869-3879.
DOI
|
18 |
Neuder LE, Keener JM, Eckert RE, Trujillo JC, Jones SL. 2009. Role of p38 MAPK in LPS induced pro-inflammatory cytokine and chemokine gene expression in equine leukocytes. Vet. Immunol. Immunopathol. 294: 192-199.
|
19 |
MacLeod AJ, Ross HB, Ozere RL, Digout G, van Rooyen CE. 1964. Lincomycin: A new antibiotic active against Staphylococci and other gram-positive cocci: Clinical and Laboratory Studies. Can. Med. Assoc. J. 14: 1056-1060.
|
20 |
Duncan IB, Jeans B. 1965. Lincomycin in hospital practice. Can. Med. Assoc. J. 93 685-691.
|
21 |
Hall IH, Schwab UE, Ward ES, Ives TJ. 2003. Effects of moxifloxacin in zymogen A or S. aureus stimulated human THP-1 monocytes on the inflammatory process and the spread of infection. Life Sci. 73: 2675-2685.
DOI
|
22 |
Nakano T, Hiramatsu K, Kishi K, Hirata N, Kadota J, Nasu M. 2003. Clindamycin modulates inflammatory-cytokine induction in lipopolysaccharide-stimulated mouse peritoneal macrophages. Antimicrob. Agents Chemother. 47: 363-367.
DOI
|
23 |
Ulich TR, Yin S, Remick DG, Russell D, Eisenberg SP, Kohno T. 1993. Intratracheal administration of endotoxin and cytokines. IV. The soluble tumor necrosis factor receptor type I inhibits acute inflammation. Am. J. Pathol. 142: 1335-1338.
|
24 |
Leigh WK, Firoz R, Richard DH, Jr., Rebecca CG, Suzanne MM. 1998. Effect of lipopolysaccharide and inflammatory cytokines on interleukin-6 production by healthy human gingival fibroblasts. Infect. Immun. 66: 608-614.
DOI
|
25 |
Ramana KV, Fadl AA, Tammali R, Reddy AB, Chopra AK, Srivastava SK. 2006. Aldose reductase mediates the lipopolysa-ccharideinduced rele-ase of inflammatory mediators in RAW264.7 murine macrophages. J. Biol. Chem. 281: 33019-33029.
DOI
|
26 |
Xu X, Li H, Hou X, Li D, He S, Wan C, et al. 2015. Punicalagin induces Nrf2/HO-1 expression via upregulation of PI3K/AKT pathway and inhibits LPS-induced oxidative stress in RAW264.7 macrophages. Mediators Inflamm. 2015: 380218.
DOI
|
27 |
Vo VA, Lee JW, Kim JY, Park JH, Lee HJ, Kim SS, et al. 2014. Phosphorylation of Akt mediates anti-Inflammatory activity of 1-p-Coumaroyl -D-Glucoside against lipopolysaccharide-induced inflammation in RAW264.7 Cells. Korean J. Physiol Pharmacol. 18: 79-86.
DOI
|